Websites relevant to the d-LIVER project:

European Commission FP7 Research
ICT Challenge 5: ICT for Health, Ageing Well, Inclusion and Governance
Challenge 5 builds on the previous research activities on health, ageing, inclusion, and governance. Nevertheless, it adapts to support new policy developments such as the Digital Agenda for Europe, the European Innovation Partnership on Active and Healthy Ageing and Horizon 2020. It adapts also to better support innovation and activities closer to the market like pre-commercial procurement actions and platforms supporting social innovation.

Other EC projects in this area:

StemBANCC aims to provide well characterised patient derived induced pluripotent stem cell lines and associated biomaterials in an accessible and sustainable bio-bank. StemBANCC also aims to demonstrate proof of concept for the utility of induced pluripotent stem cells in drug discovery for hard-to-treat disorders. The main aim of the StemBANCC project is to generate and characterise high quality human induced pluripotent stem (iPS) cell lines to study a range of chronic diseases (e.g. diabetes and dementia) and test for drug efficacy and safety.

The core objective of the SpeCCC project is to develop specialised 3D functional liver cell carrier components for use in homogeneous scalable bioreactors systems. The expected outcomes of the SpeCCC project include; 1) Specialised cell carrier component incorporating functional immortalised liver cell lines; 2) production system for application ready specialised cell carrier components; 3) homogeneous bioreactor containing specialised carrier components for integration into a bioartificial liver device (BAL); 4) homogeneous microbioreactor containing specialised carrier components for integration into a multi-microbioreactor platform for drug testing and biotransformations; and 5) multiwell plate system incorporating specialised carrier components for drug testing and toxicology applications.

The aim of the NanoBio4Trans project is to develop, optimize and validate a highly vascularised in-vivo-like bioartificial liver as an extracorporeal bioartificial liver, which is ready to be perfused with human blood plasma, and can be exploited in modern medical technology. The aim of the first version of the artificial liver is to support patients with weak liver function with an external bioartificial liver; this should be ready in 2020.

Liver patient support groups:

LIVErNORTH is a regional adult liver patient support group based at the Freeman Hospital in Newcastle upon Tyne

Our region includes Northumberland and the Scottish Borders, Tyne & Wear, Durham, Cumbria and the East Riding of Yorkshire. LIVErNORTH is run entirely by unpaid volunteers and all of our services are absolutely free to liver patients, their carers and families in the Northern Region.

some German liver patient support groups:

Die deutsche Leberstiftung

Die Deutsche Leberhilfe e.V.

Leber-Liga zur Förderung und Unterstützung chronisch Lebererkrankter e.V.: